Retinal inflammatory diseases induced by
cytokines, such as
tumor necrosis factor-α (TNF-α) are associated with an up-regulation of
intercellular adhesion molecule-1 (ICAM-1) in the
retinal pigment epithelial cells (RPECs). Retinal pigment epithelium (RPE) is a monolayer of epithelial cells that forms the outer blood-retinal barrier in the posterior segment of the eye, and is also implicated in the pathology of, such as neovascularization in
age-related macular degeneration (AMD). However, the detailed mechanisms of TNF-α-induced
ICAM-1 expression are largely unclear in human RPECs. We demonstrated that in RPECs, TNF-α could induce
ICAM-1 protein and
mRNA expression and promoter activity, and monocyte adhesion. TNF-α-mediated responses were attenuated by pretreatment with the inhibitor of
PKCs (Ro318220), PKCδ (
Rottlerin), MEK1/2 (
U0126), JNK1/2 (
SP600125), or
AP-1 (
Tanshinone IIA) and transfection with
siRNA of
TNFR1,
TRAF2, JNK2, p42, or c-Jun. We showed that TNF-α could stimulate the
TNFR1 and
TRAF2 complex formation. TNF-α-stimulated JNK1/2 was also reduced by
Rottlerin or
SP600125. However,
Rottlerin had no effect on TNF-α-induced p42/
p44 MAPK phosphorylation. We observed that TNF-α induced c-Jun phosphorylation which was inhibited by
Rottlerin or
SP600125. On the other hand, TNF-α-stimulated
ICAM-1 promoter activity was prominently lost in RPECs transfected with the point-mutated
AP-1 ICAM-1 promoter plasmid. These results suggest that TNF-α-induced
ICAM-1 expression and monocyte adhesion is mediated through a
TNFR1/
TRAF2/PKCδ/JNK1/2/c-Jun pathway in RPECs. These findings concerning TNF-α-induced
ICAM-1 expression in RPECs imply that TNF-α might play an important role in ocular
inflammation and diseases.